Future therapies for hepatitis C: where do we go from here?
- PMID: 17268539
- DOI: 10.1038/ncpgasthep0736
Future therapies for hepatitis C: where do we go from here?
Similar articles
-
New therapies: oral inhibitors and immune modulators.Clin Liver Dis. 2006 Nov;10(4):867-80. doi: 10.1016/j.cld.2006.08.013. Clin Liver Dis. 2006. PMID: 17164122 Review.
-
[Ribavirin for chronic hepatitis C: many doubts and some hope].Arq Gastroenterol. 1995 Jul-Sep;32(3):102-4. Arq Gastroenterol. 1995. PMID: 8728783 Portuguese. No abstract available.
-
Mechanism of action of interferon and ribavirin in treatment of hepatitis C.Nature. 2005 Aug 18;436(7053):967-72. doi: 10.1038/nature04082. Nature. 2005. PMID: 16107837 Review.
-
Novel approaches for therapy of chronic hepatitis C.J Clin Virol. 2006 Jun;36(2):87-94. doi: 10.1016/j.jcv.2006.02.003. Epub 2006 Mar 20. J Clin Virol. 2006. PMID: 16546442 Review.
-
Management of hepatitis C virus genotype 4.J Gastroenterol Hepatol. 2004 Nov;19(11):1233-9. doi: 10.1111/j.1440-1746.2003.03325.x. J Gastroenterol Hepatol. 2004. PMID: 15482528 Review.
Cited by
-
A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants.PLoS Comput Biol. 2010 Apr 15;6(4):e1000745. doi: 10.1371/journal.pcbi.1000745. PLoS Comput Biol. 2010. PMID: 20419154 Free PMC article.
-
Hepatitis infection in the treatment of opioid dependence and abuse.Subst Abuse. 2008 Apr 28;1:15-61. doi: 10.4137/sart.s580. eCollection 2008. Subst Abuse. 2008. PMID: 25977607 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical